KPIs & Operating Metrics(New)
Animal Health Revenue BreakdownBreakdown Of AssetsEmployee StatisticsGross Margin %Gross ProfitGross Profit AnnualGross Profit Annual %InventoriesLong Lived Assets By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Expense SegregationOpex As A % Of Total Revenue %Pharmaceuticals Revenue BreakdownPharmaceuticals Revenue Breakdown AnnualPrice Change By Region %Price Change By Region Annual %Price, Volume & Rate Change Total %Property And Equipment SegregationRate Change By Region %Rate Change By Region Annual %Revenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By Customer LocationRevenue By Customer Location %Revenue By Customer Location AnnualRevenue By Customer Location Annual %Revenue By RegionRevenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Volume Change By Region %Volume Change By Region Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Gross Profit (2016 - 2025)

Eli Lilly (LLY) has disclosed Gross Profit for 17 consecutive years, with $15.9 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 43.04% year-over-year to $15.9 billion, compared with a TTM value of $54.1 billion through Dec 2025, up 47.79%, and an annual FY2025 reading of $54.1 billion, up 47.79% over the prior year.
  • Gross Profit was $15.9 billion for Q4 2025 at Eli Lilly, up from $14.6 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $15.9 billion in Q4 2025 and bottomed at $4.8 billion in Q2 2021.
  • Average Gross Profit over 5 years is $8.0 billion, with a median of $6.8 billion recorded in 2023.
  • The sharpest move saw Gross Profit decreased 7.05% in 2023, then skyrocketed 57.45% in 2025.
  • Year by year, Gross Profit stood at $5.9 billion in 2021, then dropped by 3.29% to $5.8 billion in 2022, then surged by 31.49% to $7.6 billion in 2023, then skyrocketed by 47.11% to $11.1 billion in 2024, then skyrocketed by 43.04% to $15.9 billion in 2025.
  • Business Quant data shows Gross Profit for LLY at $15.9 billion in Q4 2025, $14.6 billion in Q3 2025, and $13.1 billion in Q2 2025.